Feedback / Questions
AT03-65 - Axcynsis Therap
https://en.prnasia.com/releases/apac/axcynsis-therapeutics-receives-fda-clearance-for-ind-application-of-at03-65-a-differentiated-cldn6-targeting-adc-powered-by-axcyndot-technology-475932.shtml
Jan 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next